- Corporate Officers - D
- De Silva Rajiv
Insider Trading History of De Silva Rajiv
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by De Silva Rajiv since 2009.
The trader's CIK number is 1453140.
At the time of the last reporting, De Silva Rajiv was the Chief Operating Offi of Endo International Plc. (stock ticker symbol ENDP).
Also see all insider trading activities at Endo International Plc.
Note that in the past
DE SILVA RAJIV also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Valeant Pharmaceuticals International (VRX) by De Silva Rajiv
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | VRX | 0 | $0 | 23,000 | $1,040,565 | 23,000 | $521,640 |
| 2009 | VRX | 20,602 | $425,297 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Amag Pharmaceuticals, Inc. (AMAG) by De Silva Rajiv
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | AMAG | 14,822 | $0 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Endo International Plc (ENDP) by De Silva Rajiv
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ENDP | 2,250 | $100,125 | 0 | $0 | 143,818 | $0 |
| 2015 | ENDP | 9,006 | $500,013 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bausch Health Companies Inc. (VRX) by De Silva Rajiv
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | VRX | 0 | $0 | 297,040 | $12,131,674 | 384,990 | $4,935,481 |
| 2011 | VRX | 6,180 | $249,665 | 0 | $0 | 83,086 | $749,994 |
| 2010 | VRX | 0 | $0 | 219,897 | $5,937,219 | 18,277 | $148,226 |
Insider trading activities at 4 companies by De Silva Rajiv:
1. Valeant Pharmaceuticals International (VRX)
2. Amag Pharmaceuticals, Inc. (AMAG)
3. Endo International Plc (ENDP)
4. Bausch Health Companies Inc. (VRX)
Table 1. Insider trading of Valeant Pharmaceuticals International (VRX) by De Silva Rajiv
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-06-09 | VRX | Sale | 23,000 | 45.24 | 1,040,565 |
| 2010-06-09 | VRX | Option Ex | 23,000 | 22.68 | 521,640 |
| 2009-08-24 | VRX | Buy | 9,007 | 24.98 | 224,994 |
| 2009-02-27 | VRX | Buy | 11,595 | 17.27 | 200,303 |
Table 2. Insider trading of Amag Pharmaceuticals, Inc. (AMAG) by De Silva Rajiv
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-05-24 | AMAG | Buy | 14,822 | .00 | 0 |
Table 3. Insider trading of Endo International Plc (ENDP) by De Silva Rajiv
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-21 | ENDP | Option Ex | 143,818 | .00 | 0 |
| 2016-03-07 | ENDP | Buy | 2,250 | 44.50 | 100,125 |
| 2015-11-11 | ENDP | Buy | 9,006 | 55.52 | 500,013 |
Table 4. Insider trading of Bausch Health Companies Inc. (VRX) by De Silva Rajiv
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-11-08 | VRX | Option Ex | 76,344 | 25.42 | 1,940,664 |
| 2012-11-08 | VRX | Sale | 76,344 | 54.04 | 4,125,706 |
| 2012-11-06 | VRX | Option Ex | 220,694 | 13.57 | 2,994,817 |
| 2012-11-06 | VRX | Sale | 220,696 | 36.28 | 8,005,968 |
| 2012-09-26 | VRX | Option Ex | 87,952 | .00 | 0 |
| 2011-08-12 | VRX | Buy | 6,180 | 40.40 | 249,665 |
| 2011-06-01 | VRX | Option Ex | 69,581 | 8.11 | 564,301 |
| 2001-06-01 | VRX | Option Ex | 13,505 | 13.75 | 185,693 |
| 2010-12-01 | VRX | Option Ex | 18,277 | 8.11 | 148,226 |
| 2010-12-01 | VRX | Sale | 219,897 | 27.00 | 5,937,219 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by De Silva Rajiv
(Chief Operating Offi of Endo International Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.